Prevalence of Amyloidosis in Trauma Patients

ConditionAmyloidosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorConsorci Sanitari de l'Alt Penedès i Garraf

About this trial

This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.

Eligibility criteria

Qualifiers

Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness > 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP > 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.

Ability to cooperate in the necessary evaluations.

Signed informed consent for inclusion in the study, either by the participant or their legal representative.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Traumatologic surgery

Treatment groups

No treatment groups listed